B cells help alloreactive T cells differentiate into memory T cells.

PubWeight™: 1.08‹?› | Rank: Top 10%

🔗 View Article (PMC 2956128)

Published in Am J Transplant on September 01, 2010

Authors

Y-H Ng1, M H Oberbarnscheidt, H C K Chandramoorthy, R Hoffman, G Chalasani

Author Affiliations

1: Department of Medicine, Division of Nephrology, National University Hospital, Singapore.

Articles citing this

Targeting B cells and antibody in transplantation. Am J Transplant (2011) 1.34

Immunomodulatory effect of mesenchymal stem cells on B cells. Front Immunol (2012) 1.01

Immune recognition and rejection of allogeneic skin grafts. Immunotherapy (2011) 0.97

B cells mediate chronic allograft rejection independently of antibody production. J Clin Invest (2014) 0.96

B cell depletion curtails CD4+ T cell memory and reduces protection against disseminating virus infection. J Immunol (2014) 0.93

CD40-independent help by memory CD4 T cells induces pathogenic alloantibody but does not lead to long-lasting humoral immunity. Am J Transplant (2013) 0.91

Origin and biology of the allogeneic response. Cold Spring Harb Perspect Med (2013) 0.87

B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells. Am J Transplant (2014) 0.86

B Cells, Antibodies, and More. Clin J Am Soc Nephrol (2015) 0.85

Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques. Am J Transplant (2012) 0.85

Transient B-cell depletion combined with apoptotic donor splenocytes induces xeno-specific T- and B-cell tolerance to islet xenografts. Diabetes (2013) 0.82

Role of Memory T Cells and Perspectives for Intervention in Organ Transplantation. Front Immunol (2015) 0.81

Effector mechanisms of rejection. Cold Spring Harb Perspect Med (2013) 0.79

B-cell-dependent memory T cells impede nonmyeloablative mixed chimerism induction in presensitized mice. Am J Transplant (2011) 0.79

B Cell Depletion With an Anti-CD20 Antibody Enhances Alloreactive Memory T Cell Responses After Transplantation. Am J Transplant (2015) 0.78

T-cell activation and transplantation tolerance. Transplant Rev (Orlando) (2011) 0.78

Lessons and limits of mouse models. Cold Spring Harb Perspect Med (2013) 0.78

B-cell depletion improves islet allograft survival with anti-CD45RB. Cell Transplant (2012) 0.78

CD4 T Cell Help via B Cells Is Required for Lymphopenia-Induced CD8 T Cell Proliferation. J Immunol (2016) 0.77

Alloreactive CD8 T-cell primed/memory responses and accelerated graft rejection in B-cell-deficient sensitized mice. Transplantation (2011) 0.76

A Paradigm Shift on the Question of B Cells in Transplantation? Recent Insights on Regulating the Alloresponse. Front Immunol (2017) 0.75

B Cell Immunity in Solid Organ Transplantation. Front Immunol (2017) 0.75

T-cell allorecognition of donor glutathione S-transferase T1 in plasma cell-rich rejection. World J Hepatol (2017) 0.75

Articles cited by this

A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature (1991) 13.19

Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol (2002) 9.45

Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med (2002) 7.11

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature (1996) 6.61

Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells. J Exp Med (2002) 5.09

Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol (2000) 4.73

Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol (2007) 4.46

Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med (2003) 4.35

Cutting edge: rapid in vivo killing by memory CD8 T cells. J Immunol (2003) 4.25

CD27 is required for generation and long-term maintenance of T cell immunity. Nat Immunol (2000) 3.84

Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol (2003) 3.82

Interleukin 7 regulates the survival and generation of memory CD4 cells. J Exp Med (2003) 3.76

Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol (2007) 3.63

Quantitative studies of blood and bone marrow neutrophils in normal mice. Am J Physiol (1968) 3.33

Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol (1999) 2.79

T cell activation in rheumatoid synovium is B cell dependent. J Immunol (2001) 2.73

Generation of CD8 T cell memory is regulated by IL-12. J Immunol (2007) 2.69

Memory CD4 T cells emerge from effector T-cell progenitors. Nature (2008) 2.62

Successful T cell priming in B cell-deficient mice. J Exp Med (1995) 2.52

Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J Immunol (2006) 2.40

B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J Immunol (1995) 2.29

Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J Exp Med (2003) 2.27

Primed allospecific T cells prevent the effects of costimulatory blockade on prolonged cardiac allograft survival in mice. Am J Transplant (2002) 2.18

B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med (2000) 2.02

CD8 T cell memory in B cell-deficient mice. J Exp Med (1996) 1.97

A critical role for B cells in the development of memory CD4 cells. J Immunol (2000) 1.97

Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice. J Virol (1998) 1.86

B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection. J Immunol (2006) 1.86

During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion. J Immunol (2005) 1.81

Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol (2002) 1.81

An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry. J Immunol Methods (1994) 1.76

Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig. J Immunol (1996) 1.75

Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells. Int Immunol (2004) 1.62

Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs. Proc Natl Acad Sci U S A (2002) 1.60

Requirement of B cells for generating CD4+ T cell memory. J Immunol (2009) 1.60

A specific role for B cells in the generation of CD8 T cell memory by recombinant Listeria monocytogenes. J Immunol (2003) 1.59

Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection. J Immunol (1998) 1.56

B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. J Immunol (1999) 1.54

Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients. J Immunol (2002) 1.50

Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells. J Exp Med (1996) 1.50

Distinct role of surface lymphotoxin expressed by B cells in the organization of secondary lymphoid tissues. Immunity (2002) 1.49

HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction. Am J Transplant (2005) 1.46

Cutting edge: IL-7-independent regulation of IL-7 receptor alpha expression and memory CD8 T cell development. J Immunol (2006) 1.43

CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. J Immunol (1999) 1.35

B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J Immunol (2006) 1.34

Contribution of naïve and memory T-cell populations to the human alloimmune response. Am J Transplant (2009) 1.34

Two levels of help for B cell alloantibody production. J Exp Med (1996) 1.31

4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses. J Immunol (2004) 1.30

HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant (2004) 1.27

Characterization of intra-graft B cells during renal allograft rejection. Kidney Int (2008) 1.17

BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection. Kidney Int (2005) 1.16

In remembrance of things past: memory T cells and transplant rejection. Immunol Rev (2003) 1.10

Passive transfer of immunity to skin homografts in rats. Ann N Y Acad Sci (1962) 1.09

Effector T cell differentiation and memory T cell maintenance outside secondary lymphoid organs. J Immunol (2006) 1.08

Prolonged antigen persistence within nonterminal late endocytic compartments of antigen-specific B lymphocytes. J Immunol (2001) 1.06

Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation. Circulation (1998) 1.01

CD4 T cell-mediated rejection of cardiac allografts in B cell-deficient mice. J Immunol (2008) 1.00

Deficient CD4+ T cell priming and regression of CD8+ T cell functionality in virus-infected mice lacking a normal B cell compartment. J Immunol (2003) 0.98

Immunological memory in B-cell-deficient mice conveys long-lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells. Immunology (2001) 0.96

Role for inducible costimulator in control of Salmonella enterica serovar Typhimurium infection in mice. Infect Immun (2006) 0.92

Differential infiltration by CD45RO and CD45RA subsets of T cells associated with human heart allograft rejection. Am J Pathol (1993) 0.89

The roles of CD8 central and effector memory T-cell subsets in allograft rejection. Am J Transplant (2008) 0.87

T and B cell cooperation: a dance of life and death. Transplantation (2005) 0.87

Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation. Am J Transplant (2002) 0.85

Impact of ELISA-detected anti-HLA antibodies on pediatric cardiac allograft outcome. Hum Immunol (2005) 0.84

Predominant infiltration of rejecting human renal allografts with T cells expressing CD8 and CD45RO. Transplantation (1995) 0.84

Analyzing cytotoxic T lymphocyte activity: a simple and reliable flow cytometry-based assay. J Immunol Methods (1997) 0.83

Late acute rejection in long-term renal allograft recipients. Diagnostic and predictive value of circulating activated T cells. Transplantation (1994) 0.82

Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-up. Clin Transpl (2006) 0.82

Post-transplant donor-specific antibody production and graft outcome in kidney transplantation: results of sixteen-year monitoring by flow cytometry. Clin Transpl (2006) 0.81

Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes. Transplantation (2000) 0.76

DIFFERENTIAL EFFECTS OF SPECIFIC ANTISERA ON THE REJECTION OF ALLOGENEIC AND XENOGENEIC SKIN GRAFTS BY SUBLETHALLY X-IRRADIATED MICE. J Immunol (1963) 0.76

Articles by these authors

(truncated to the top 100)

Symptom assessment in schizophrenic prodromal states. Psychiatr Q (1999) 3.09

Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856). Br J Cancer (1992) 2.91

An outbreak of Escherichia coli O157:H7 infection from unpasteurized commercial apple juice. Ann Intern Med (1999) 2.56

A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr (1979) 2.32

Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst (2001) 2.09

Embryonic-fetal erythroid characteristics of a human leukemic cell line. Proc Natl Acad Sci U S A (1980) 1.90

Role of members of the Wnt gene family in human hematopoiesis. Blood (1998) 1.86

The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. J Immunol (1986) 1.85

Erythroid colony formation by polycythemia vera bone marrow in vitro. Dependence on erythropoietin. J Clin Invest (1977) 1.79

Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol (2001) 1.79

Excessive zinc ingestion. A reversible cause of sideroblastic anemia and bone marrow depression. JAMA (1990) 1.78

Human CD34(+) stem cells express the hiwi gene, a human homologue of the Drosophila gene piwi. Blood (2001) 1.74

The treatment of lead poisoning from gunshot wounds with succimer (DMSA) J Toxicol Clin Toxicol (1994) 1.72

Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes. J Immunol (1988) 1.62

Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma. Bone Marrow Transplant (2006) 1.52

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophr Res (2003) 1.47

Relapsing polychondritis: a paraneoplastic syndrome associated with myelodysplastic syndromes. Am J Hematol (1992) 1.43

2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia. Blood (2000) 1.43

Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia. J Clin Oncol (1997) 1.41

Enriched hematopoietic stem cells: basic biology and clinical utility. Biol Blood Marrow Transplant (1995) 1.41

Hematologic malignancies associated with primary mediastinal germ-cell tumors. Ann Intern Med (1985) 1.41

Successful use of recombinant activated factor VII (Novoseven) in controlling severe intra-abdominal bleeding after liver needle biopsy. Thromb Haemost (2002) 1.40

Virgin olive oil as a source of phytoestrogens. Eur J Clin Nutr (2012) 1.39

Treatment of smoke inhalation in five horses. J Am Vet Med Assoc (1993) 1.38

Alanine-scanning mutagenesis of Bacillus subtilis trp RNA-binding attenuation protein (TRAP) reveals residues involved in tryptophan binding and RNA binding. J Mol Biol (1997) 1.38

The modulation contrast microscope. Nature (1975) 1.34

Ethnic differences in optic nerve head topography. J Glaucoma (1995) 1.33

Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia. N Engl J Med (1977) 1.33

The extensive homology between mRNA sequences of normal and SV40-transformed human fibroblasts. Cell (1977) 1.31

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample. Schizophr Res (2003) 1.29

von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Res (2001) 1.27

Polymeric surface modifications of tantalum stents. J Endovasc Surg (1996) 1.27

Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies. J Immunol (1987) 1.26

Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood (1990) 1.24

Photoreceptor shedding is initiated by light in the frog retina. Science (1976) 1.22

Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates. Am J Transplant (2013) 1.22

Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Curr Opin Hematol (2000) 1.22

Role of c-kit ligand in the expansion of human hematopoietic progenitor cells. Blood (1992) 1.21

Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Haemost (2005) 1.21

Increased circulating nitrogen oxides after human tumor immunotherapy: correlation with toxic hemodynamic changes. J Natl Cancer Inst (1992) 1.20

Evidence that the major surface proteins of three Leishmania species are structurally related. Mol Biochem Parasitol (1985) 1.20

Acute fluoride poisoning in a New Mexico elementary school. Pediatrics (1980) 1.20

Tertiary lymphoid tissues generate effector and memory T cells that lead to allograft rejection. Am J Transplant (2007) 1.19

Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. I. In vivo inhibition of peritoneal leukocytosis. Surgery (1978) 1.19

Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol (1989) 1.19

Immunofluorescent identification of human megakaryocyte colonies using an antiplatelet glycoprotein antiserum. Blood (1981) 1.19

A prospective trial of new versus refurbished cardiac pacemakers: a Canadian experience. Can J Cardiol (1989) 1.18

Patient and tumor characteristics of colon cancers with microsatellite instability: a population-based study. Cancer Epidemiol Biomarkers Prev (2000) 1.16

Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro. J Clin Invest (1988) 1.16

Improvement in speech perception and production abilities in children using a multichannel cochlear implant. Laryngoscope (1990) 1.14

Partial characterization of cytotoxic cells infiltrating sponge matrix allografts. Transplantation (1979) 1.14

Antibody-mediated aplastic anemia and diffuse fasciitis. N Engl J Med (1979) 1.13

Iguana-associated salmonellosis in children. Pediatr Infect Dis J (1995) 1.13

Diamond-Blackfan syndrome: lymphocyte-mediated suppression of erythropoiesis. Science (1976) 1.13

Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow. J Clin Invest (1990) 1.10

Screening for pregnancy and contraceptive use among women admitted to a Denver detoxification center. Public Health Rep (1998) 1.10

Human hematopoietic stem cell adherence to cytokines and matrix molecules. J Clin Invest (1992) 1.09

Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease. Bone Marrow Transplant (2000) 1.09

What are RBC-transfusion-dependence and -independence? Leuk Res (2010) 1.09

Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. Hum Gene Ther (2001) 1.09

T cell chronic lymphocytic leukemia: presence in bone marrow and peripheral blood of cells that suppress erythropoiesis in vitro. Blood (1978) 1.09

The effect of tailoring a model HIV prevention program for local adolescent target audiences. AIDS Educ Prev (2000) 1.08

Effects of recombinant human tumor necrosis factor alpha, recombinant human gamma-interferon, and prostaglandin E on colony formation of human hematopoietic progenitor cells stimulated by natural human pluripotent colony-stimulating factor, pluripoietin alpha, and recombinant erythropoietin in serum-free cultures. Cancer Res (1986) 1.07

The characterization, molecular cloning, and expression of a novel hematopoietic cell antigen from CD34+ human bone marrow cells. Blood (1997) 1.07

Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities. Blood (1996) 1.07

A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood (1996) 1.07

Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts? Blood Cells (1994) 1.06

Induction of erythropoietic colonies in a human chronic myelogenous leukemia cell line. Blood (1979) 1.04

Selective up-regulation of type II inosine 5'-monophosphate dehydrogenase messenger RNA expression in human leukemias. Cancer Res (1991) 1.04

Leukemia inhibitory factor upregulates cytokine expression by a murine stromal cell line enabling the maintenance of highly enriched competitive repopulating stem cells. Blood (1996) 1.03

TGF-beta 1 modulates EGF-stimulated phosphatidylinositol 3-kinase activity in human airway smooth muscle cells. Am J Physiol (1997) 1.03

Recruitment of unsensitized circulating lymphocytes to sites of allogeneic cellular interactions. Transplantation (1982) 1.02

Eosinophilic fasciitis. Clin Rheum Dis (1982) 1.01

CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells. Exp Hematol (1999) 0.99

Vi-like' and VF-like' leads for continuous electrocardiographic monitoring. Br Heart J (1972) 0.98

Constitutive expression of platelet glycoproteins by the human leukemia cell line K562. Blood (1982) 0.98

Patient recovery from type A botulism: morbidity assessment following a large outbreak. Am J Public Health (1981) 0.97

Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia. Blood (1992) 0.97

Marrow-derived heparan sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines. Exp Hematol (1995) 0.96

Persistence of human multilineage, self-renewing lymphohematopoietic stem cells in chimeric sheep. Blood (1993) 0.96

Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells. Blood (1995) 0.96

Partially differentiated ex vivo expanded cells accelerate hematologic recovery in myeloablated mice transplanted with highly enriched long-term repopulating stem cells. Blood (1996) 0.96

Predictors of subjective fatigue among individuals with rheumatoid arthritis. Arthritis Rheum (1998) 0.96

Granulocyte colony-stimulating factor induction of normal human bone marrow progenitors results in neutrophil-specific gene expression. Blood (1995) 0.95

Feline preleukemia: an animal model of human disease. Yale J Biol Med (1979) 0.95

Signal transduction by the receptors for thrombopoietin (c-mpL) and interleukin-3 in hematopoietic and nonhematopoietic cells. Blood (1995) 0.95

The relative quiescence of hematopoietic stem cells in nonhuman primates. Blood (2001) 0.95

Acquired amegakaryocytic thrombocytopenic purpura: a syndrome of diverse etiologies. Blood (1982) 0.95

Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis. Blood Cells (1991) 0.95

Preservation and transplantation of human cadaver kidneys. Transplantation (1972) 0.95

Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp Hematol (1994) 0.95

Pinless external fixation. Indications and preliminary results in tibial shaft fractures. Clin Orthop Relat Res (1998) 0.94

Characterization of the human burst-forming unit-megakaryocyte. Blood (1989) 0.94

Modification of bacterial artificial chromosome clones using Cre recombinase: introduction of selectable markers for expression in eukaryotic cells. Genome Res (1998) 0.94

Generation of human natural killer cells from immature progenitors does not require marrow stromal cells. Blood (1994) 0.94

Lymphoblastic-like leukemic transformation of polycythemia vera. Ann Intern Med (1978) 0.94

Potentiation of human erythropoiesis in vitro by thyroid hormone. Nature (1978) 0.93

Further phenotypic characterization and isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor. Blood (1992) 0.93

Activation of p55 tumor necrosis factor-alpha receptor-1 coupled to tumor necrosis factor receptor-associated factor 2 stimulates intercellular adhesion molecule-1 expression by modulating a thapsigargin-sensitive pathway in human tracheal smooth muscle cells. Mol Pharmacol (2000) 0.93

Interleukin-11 inhibits adipogenesis and stimulates myelopoiesis in human long-term marrow cultures. Blood (1993) 0.93